chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 11.0
Sex: F
Vaccine: VARCEL
Symptoms: Visual acuity tests normal
Clinical narrative: Information has been received from a physician via in a published article, concerning a 11 year old patient with a seizure disorder and a history of mild eczema, and results of an ocular examination one year prior which were normal, who was vaccinated with a dose of VARIVAX 0.5 mL into the left deltoid without any resulted skin reaction. Concomitant therapy included daily oral Levetiracetam to treat the seizure disorder. One week following administration of the vaccine, the patient developed rhinitis and a mild fever that lasted 2 days. Two weeks following the vaccination, the patient noted blurry vision and photophobia in the right eye and her mother noted 3 whites spots on the cornea and was referred to the physician for new-onset blurry vision. On examination, visual acuity measured 20/30 OD and 20/20 OS. Corneal sensation was normal in both eyes. Intraocular pressure measured 14 mm Hg OD and 18 mm Hg OS. There was no conjunctival injection or anterior chamber inflammation. In the right cornea, there were several well circumscribed avascular opacities that appeared to be white blood cells at varying stromal depths. The left eye was unaffected. The posterior segment examination results were normal in both eyes. Epstein-Barr virus DNA was not detected by polymerase chain reaction. The patient was treated with a 1 month course of Prednisolone acetate, 1 %, starting at 4 times per day, with resolution of the interstitial keratitis at 2 weeks and return of visual acuity to 20/20. At the 6 month follow up visit, there was no sign of reoccurrence. Comment: Complications of VARIVAX have included disease caused by both wild type and Oka strain varicella zoster virus. There are few reports of ocular manifestations after varicella vacinnation in the literature, and they found no previous reports describing avascular interstitial keratitis. In the case that they had reported, the close temporal association of the vaccination and the development of a corticosteroid responsive keratitis lead them to suggest that this complication represented an immune mediated response to the vaccine strain. One possible explanation for the unilaterality is that the patient rubbed one eye with a hand that had previously touched her site of inoculation, leading to unilateral antigen presentation to the cornea and unilateral disease. Unilateral disease had frequently been described following smallpox vaccination, presumably from this type of touch. In addition, systemic disease may also manifest unilaterally. Immune medicated interstitial keratitis should be recognized as a possible adverse effect of the VARIVAX vaccine. No further information is available.
Sex: U
Vaccine: VARCEL
Symptoms: Injection site erythema
Clinical narrative: Information has been received from a registered nurse, via health department, concerning a patient who was vaccinated with VARIVAX (Merck). "Within the last 2 weeks" the patient developed erythema at the injection site after receiving VARIVAX (Merck). The patient had sought medical attention. The outcome of the patient's adverse effect was not reported. In follow-up the registered nurse did not provide specific identifying information as she reported that information was already sent. This is one of several reports from the same source. Additional information has been requested.
Age: 1.26
Sex: F
Vaccine: HEPA, MMR, VARCEL
Symptoms: Herpes zoster, Rash vesicular
Clinical narrative: Information has been received from a registered nurse concerning a 46 month old female with no pertinent medical history and no drug reactions/allergies who on 19-JUN-2006 was vaccinated SQ with the first dose of VARIVAX (Merck) (LOT# 652448/0947R). Second suspect vaccine included the first dose of VAQTA IM (LOT# 653619/0144F), and the first dose of MMR II SQ (LOT# 653317/0211F). There was no illness at the time of vaccination. On 04-FEB-2009 the patient experienced vesicular clusters on right hand and forearm-probable shingles cover sleeve and glove (2 visits before diagnoses). Subsequently, the patient was recovered from the adverse event. It was reported that the patient sought medical attention: Doctor Visit. Additional information has been requested. This is in follow-up to report (s) previously submitted on 5/15/2009.  Information has been received from a registered nurse concerning a 46 month old female with no pertinent medical history and no drug reactions/allergies who on 19-JUN-2006 was vaccinated SQ with the first dose of VARIVAX (Merck) (Lot # 652448/0947R).  Second suspect vaccine included the first dose of VAQTA IM (LOT# 653619/0144F), and the first dose of MMR II SQ (LOT# 653317/0211F).  There was no illness at the time of vaccination.  On 04-FEB-2009 the patient experienced vesicular clusters on right hand and forearm-probable shingles cover sleeve and glove (2 visits before diagnoses).  Subsequently, the patient was recovered from the adverse event.  It was reported that the patient sought medical attention:  Doctor Visit.  No further information is available.
Sex: U
Vaccine: VARCEL
Symptoms: Injection site erythema
Clinical narrative: Information has been received from a registered nurse, via health department, concerning a patient who was vaccinated with VARIVAX (Merck).  "Within the last 2 weeks" the patient developed erythema at the injection site after receiving VARIVAX (Merck).  The patient had sought medical attention.  The outcome of the patient's adverse effect was not reported.  In follow-up the registered nurse did not provide specific identifying information as she reported that information was already sent.  This is one of several reports from the same source.  Additional information has been requested.
Age: 1.1
Sex: M
Vaccine: VARCEL
Symptoms: Incorrect storage of drug
Clinical narrative: Information has been received from a licensed practical nurse concerning a female who on an unspecified date was vaccinated with the second dose of VARIVAX (Oka/Merck) (route and site not reported) which was improperly stored. No symptoms reported. the patient received either lot number 658423/11800 or lot number 659065/1358U. The nurse did not have the patient's chart and wasn't sure which one she received. Follow-up information was received from the licensed practical nurse concerning who reported that the patient was a male. On 19-Jan-2009 the patient was vaccinated with the first dose of VARIVAX (Oka/Merck) (lot number 660402/0217X) IM (site not reported). The freezer temperature got warm and the state health department recommended repeating the dose. It was unknown if there was a illness at time of vaccination. Additional information has been requested.
Sex: F
Vaccine: VARCEL
Symptoms: Rash generalised, Rash macular, Rash pruritic
Clinical narrative: Information has been received from a pharmacist concerning a female who on 10-FEB-2009 was vaccinated with her first dose of VARIVAX (Merck) (lot number and site not reported) 0.5ml SQ. There was no concomitant medication. On 10-FEB-2009 after receiving a dose of VARIVAX (Merck) the patient experienced a generalized rash. The rash was described as macular and itchy. The patient's generalized rash persists. Additional information has been requested.
Age: 1.1
Sex: M
Vaccine: VARCEL
Symptoms: Mood altered, Pyrexia
Clinical narrative: Information has been received from a consumer concerning her approximately 20 month old son with no pertinent medical history and no drug reactions or allergies, who on 25-JUL-2008 was vaccinated with a dose of VARIVAX (Merck). Concomitant therapy included a dose PREVNAR. The child's mother reported that he received VARIVAX (Merck) and experienced high fever that would not do down with TYLENOL. The child also experienced moodiness after receiving the vaccine. At time of reporting, the patient had recovered. The patient sought medical attention as his mother called the office. There were no lab or diagnostic studies performed. Follow up information has been received from an office member of a physician's office who reported that the patient received the VARIVAX (Oka/Merck) on 25-JUL-2008 but was not  a patient at their office at that time. It was not given at their office. The consumer also reported that the patient experienced an adverse event with HPV-77 (WAES # 0902USA02199) and MMR II (WAES # 0902USA01781). Additional information has been requested.
Sex: F
Vaccine: VARCEL
Symptoms: Injection site rash, Pain in extremity, Varicella post vaccine
Clinical narrative: Information has been received from a registered nurse concerning a female who on approximately 30-JAN-2009, "about two weeks ago" was vaccinated with VARIVAX (Merck) (lot number, route and site not reported).  On approximately 05-FEB-2009 "one week later" the patient developed a rash at the injection site about 4cm in size with pain in the arm.  She also developed 4 lesions on the arm and one lesion on the abdomen.  The patient sought medical attention.  The patient's outcome was unknown.  Follow up information was received.  There was another physician from a different practice involved that saw the patient with the reaction who diagnosed the chickenpox.  The patient was frustrated with the situation as she received VARIVAX (Merck) before attempting to conceive which in itself was a stressful situation.  To add to things her husband never had chickenpox and was worried about transmission.  Additional information has been requested.
Age: 12.0
Sex: F
Vaccine: VARCEL
Symptoms: Antibody test negative
Clinical narrative: Information has been received from  a physician concerning an approximately 12 year old female with no medical history or allergy who on 11-SEP-1997 was vaccinated with VARIVAX (Oka/Merck) (lot# not reported)0. There was no concomitant medication. Subsequently the patient's "varicella titer" was less than "0.90" after having 2 doses of VARIVAVX (Oka/Merck). No adverse effect reported. The patient was seen by the physician. Additional information has been requested.
Age: 1.1
Sex: F
Vaccine: VARCEL
Symptoms: Rash
Clinical narrative: Information has been received from a physician assistant concerning a 13 month old female child who was vaccinated with VARIVAX (Merck). The child developed a rash after receiving VARIVAX (Merck). The specifics of the vaccination were not known as the physician assistant treated the mother of the child. As of 11-FEB-2009 the child was not recovered. The mother of the child with rash was pregnant and had not had varicella. The mother had no symptoms at the time of reporting. The mother had called office for medical attention. Additional information has been requested.
Age: 1.0
Sex: M
Vaccine: HEPA, VARCEL
Symptoms: Varicella post vaccine
Clinical narrative: Information has been received from a nurse concerning a 12 to 15 month old male who in 2009 was vaccinated with a 0.5 ml dose of VARIVAX (Merck). Concomitant therapy included a dose of VAQTA (manufacturer unspecified). Recently, about a week after receiving VARIVAX (Merck), the patient developed a full case of chicken pox. Unspecified medical attention was sought. At the time of this report, the outcome was unknown. Additional information is not expected.
Age: 4.0
Sex: M
Vaccine: MMR, VARCEL
Symptoms: Injection site cellulitis, Injection site erythema, Injection site induration
Clinical narrative: Information has been received from a physician concerning a 4 year old male patient who on 11-FEB-2009 was vaccinated with the second 0.5ml dose of VARIVAX (Lot # 661998/1389X) and with a dose of MMR II. On 12-FEB-2009 the patient experienced large red hard cellulitis at the injection site after vaccination. The patient sought unspecific medical attention. At the time of reporting the patient had not recovered. Additional information has been requested.
Age: 1.0
Sex: F
Vaccine: VARCEL
Symptoms: Varicella post vaccine
Clinical narrative: Information has been received from a licensed visiting nurse concerning a 12 month old female patient with no known drug reactions/allergies and a history of eczema who on 10-FEB-2006 was vaccinated subcutaneously with a 0.5ml dose of VARIVAX (Merck) (Lot # 652082/0943R). There was no concomitant medication. The nurse mentioned that within 42 days of vaccination the patient got chickenpox. The patient sought unspecific medical attention. The patient recovered on an unknown date. Additional information has been requested. Follow up information was received from a licensed visiting nurse concerning a now 4 year old female patient who presented to the clinic for complete physical examination. It was reported that the patient was getting the second dose of VARIVAX. It was reporte the the patient broke out in chickenpox for twi weeks after receiving initial vaccine at 12 months of age. It was reported that they lasted approximately seven days the first time. It was reported that the patient had recovered. No further informatin is available.
Age: 9.0
Sex: F
Vaccine: VARCEL
Symptoms: Herpes zoster, Skin lesion
Clinical narrative: Information has been received from a physician concerning a 15 year old female with no pertinent medical history and no drug reactions or allergies who on 28-JUL-2003 was vaccinated SQ with the first 0.5ml dose of VARIVAX (Merck). There was no concomitant medication. On approximately 16-JAN-2009 the patient developed shingles. The patient was in office to see the physician on 16-JAN-2009. At that time, the patient had lesions on the right side of chest. The physician prescribed VALTREX. At the time of this report, the patient was recovered. Additional information has been requested. This is in follow-up to report (s) previously submitted on 5/15/2009.  Information has been received from a physician concerning a 15 year old female with no pertinent medical history and no drug reactions or allergies who on 28-JUL-2003 was vaccinated SQ with the first 0.5ml dose of VARIVAX (Merck).  There was no concomitant medication.  On approximately 16-JAN-2009 the patient developed shingles.  The patient was in ofice to see the physician on 16-JAN-2009.  At that time, the patient had lesions on the right side of chest.  The physician prescribed VALTREX.  At the time of this report, the patient was recovewred.  Follow-up information was received from the office.  It was reported that the 15 year old patient no pre-existing allergies, birth defects or medical conditions developed shingles on 16-JAN-2009.  So varicella vaccine booster dose was not given.  No adverse effect.  The patient was doing well.  No further information is available.
Sex: U
Vaccine: VARCEL
Symptoms: Injection site reaction
Clinical narrative: Information has been received from a licensed practical nurse concerning two patients who on 16-FEB-2009 was vaccinated subcutaneously with the second 0.5ml dose of VARIVAX (Merck) (Lot # 661994/1390X). The nurse reported that after vaccination the patients developed injection site reactions. The patients sought medical attention went to the office. At the time of reporting the patients were recovering. This is one of two cases received from the same source. Additional information has been requested.
Age: 4.0
Sex: M
Vaccine: VARCEL
Symptoms: Varicella post vaccine
Clinical narrative: Information has been received from a consumer concerning her 4 year old son with no drug reactions or allergies who, "about 3 years ago", in approximately 2006 was vaccinated with a first dose of VARIVAX (Merck). "A few days ago", on 17-FEB-2009 the patient developed a breakthrough of chicken pox and had less than 20 lesions. Unspecified medical attention was sought but not laboratory test was performed. The patient was scheduled to receive his second dose of VARIVAX (Merck) in the next two weeks. At the time of this report, 18-FEB-2009, the event persisted. The patient's twin brother also experienced an AE following vaccination (WAES# 0902USA04167). Additional information has been requested.
Age: 11.0
Sex: F
Vaccine: VARCEL
Symptoms: Herpes zoster, Pruritus, Rash vesicular, Varicella zoster virus serology positive
Clinical narrative: Information has been received from a physician assistant concerning a 13 year old male patient with no drug reactions/allergies who was vaccinated with VARIVAX (Merck). On 15-FEB-2009 the patient had shingles, extensive vesicles on T1 on the right side of chest, back and axilla and slight pain on the right side. The patient was being treated with acyclovir. The patient had visited office for medical attention. At the time of reporting the patient's adverse events persisted. Follow-up information has been received from the physician assistant that the 13 year old female (not male) patient with acne, seasonal allergy and Seasonal allergic rhinitis who was vaccinated with VARIVAX (Merck) (lot # 612228/1503B) SQ into the deltoid of her left arm on 29-APR-2006 for her first dose. On 04-APR-2007 the patient was vaccinated with VARIVAX (Merck) (lot # reported as "9311507") SQ into the deltoid of her right arm for her second dose. Concomitant medication included over the counter unspecified antihistamine, and topical acne cream. On 15-FEB-2009 the patient experienced shingles and herpes zoster that was located in T1 dermatome. There were numerous scattered lesions on upper of her right chest and upper of her right back. It was also reported the patient had an extensive vesicular rash along T1 dermatome and experienced itching. Subsequently, the patient recovered from the adverse events. The patient was enrolled in the Varicella Zoster Virus Identification Program to identify if VZV is present and if it is present to identify if it is associated with the wild-type (WT) VZV strain or with the OKA/Merck vaccine VZV strain. The sample of the lesion was collected on 20-FEB-2009. The sample was taken from the upper right chest, back and right axilla. Follow-up information has been received that the final VZVIP PCR results for the specimen were Wild Type Strain. Follow-up information has been received that the adequate specimen, which was from a lesion (scab), was sent to laboratory on 21-FEB-2009 and arrived in laboratory on 24-FEB-2009. The VZV DNA was amplified and the VZV strain identification showed Wild-Type. Other identification number was associated with this case VZVIP 13297012695. Additional information has been requested.
Age: 1.0
Sex: F
Vaccine: VARCEL, HEPA, HIBV, MMR, PNC
Symptoms: Discomfort, Herpes simplex, Oral herpes
Clinical narrative: Information has been received from a consumer concerning her 13 month old daughter with no pertinent medical history or drug reactions/allergies who on 29-DEC-2008 was vaccinated with the first dose of VARIVAX (Merck) (LOT# not reported). There were no concomitant medications. On 15-FEB-2009 the patient was diagnosed with herpes simplex. The patient developed a single lesion inside the lower lip on 15-FEB-2009. The patient was examined in a local emergency room and the lesion was diagnosed as herpes simplex. The patient was then examined in the physician's office because the "cold sore" lesion caused discomfort. No therapy was prescribed. The patient was recovering from the herpes simplex. It was reported that the patient sought medical attention: emergency room. Additional information has been requested.
Age: 1.0
Sex: F
Vaccine: VARCEL, HEPA, HIBV, MMR, PNC
Symptoms: Eating disorder, Malaise, Oral herpes, Stomatitis
Clinical narrative: Information has been received from a consumer concerning her 13 month old daughter with no pertinent medical history or drug reactions/allergies who on 29-DEC-2008 was vaccinated with the first dose of VARIVAX (Merck) (LOT# not reported). There were no concomitant medications. On 15-FEB-2009 the patient was diagnosed with herpes simplex. The patient developed a single lesion inside the lower lip on 15-FEB-2009. The patient was examined in a local emergency room and the lesion was diagnosed as herpes simplex. The patient was then examined in the physician's office because the "cold sore" lesion caused discomfort. No therapy was prescribed. The patient was recovering from the herpes simplex. It was reported that the patient sought medical attention: emergency room. Additional information has been requested.
Age: 14.0
Sex: M
Vaccine: VARCEL
Symptoms: Blister, Influenza, Rash vesicular
Clinical narrative: Information has been received from a registered nurse concerning a 14 year male with no relevant medical history reported and no allergies reported, who on 23-MAR-1998 was vaccinated SQ with the first 0.5mL dose of VARIVAX (Oka/Merck) and on 26-JAN-2009 was vaccinated SQ with second 0.5mL dose of VARIVAX (Oka/Merck) (lot number 662441/1326X)> There was no concomitant medication. On 02-FEB-2009, the patient was seen at the office and was diagnosed with the flu. On 19-FEB-2009 the patient's mother called the office and reported that the child had a couple of bumps on his body. On 20-FEB-2009, he was seen and had about 20 varicella-like vesicles in  face, arms and trunks. Additional information has been requested.
Age: 11.0
Sex: M
Vaccine: VARCEL
Symptoms: Myositis
Clinical narrative: Information has been received from a nurse concerning a 11 year old male patient with autoimmune disorder who about 5 years ago, in approximately 2004, was vaccinated with a dose of 0.5 mL VARIVAX (Oka/Merck). About 5 years ago, in approximately 2004, within 48 hours of receiving VARIVAX (Oka/Merck), the patient developed myositis. The patient sought unspecified medical attention. No further information is available.
Age: 0.6
Sex: F
Vaccine: VARCEL
Symptoms: Injection site rash
Clinical narrative: Information has been received from a licensed practical nurse concerning a 13 year old female patient who on 16-FEB-2009 was vaccinated subcutaneously with the second 0.5ml dose of VARIVAX (Lot # 661994/1390X). The nurse reported that after vaccination the patient developed injection site reactions. The patient had a rash at the injection site approximately 3-4 cm in diameter. The patient sought medical attention by a phone call. At the time of reporting the patient was recovering. This is one of two cases received from the same source. Additional information has been requested.
Age: 2.0
Sex: F
Vaccine: VARCEL
Symptoms: Varicella post vaccine
Clinical narrative: Information has been received from a consumer concerning her 24 month old granddaughter. The caller reported that she had shingles about a month and a half ago and she went to visit her grandchildren. The youngest got chickenpox from her and she was under one year of age and had not been vaccinated yet. However, the older child on approximately 23-JAN-2009 got chickenpox from the younger child and she was vaccinated with a dose of VARIVAX (lot not provided) a couple months before. The chickenpox was not as severe on the older child as it was on the younger one. No further information is available.
Age: 1.19
Sex: F
Vaccine: FLU3, VARCEL
Symptoms: Injection site erythema, Injection site swelling, Rash erythematous
Clinical narrative: Information has been received from a consumer concerning her almost 15 month old daughter with no known medical history who on 05-FEB-2009 was vaccinated with a dose of VARIVAX (Merck).  Concomitant therapy included vitamins (unspecified).  The consumer stated that a few days post vaccination the patient developed a reaction at the injection site of her right arm; there was a small pin prick at the site.  Then a few days later this developed into a bigger, red, swollen area.  She also had a few faint red marks on her face.  The physician was not able to tell if the marks on her face were chickenpox.  The patient sought medical attention went to the office.  At the time of reporting the patient had not recovered.  Additional information has been requested. This is in follow-up to report(s) previously submitted on 5/15/2009. Follow up information was received from a physician. It was reported that on 05-FEB-2009, the patient with good general health was vaccinated with a first dose of VARIVAX (Merck) (Lot # 661969/1392X) in the right arm and with a second dose of FLUZONE, Lot # UT2783DA) into the right leg. On 14-FEB-2009, the patient had a welt on the right upper arm, there was no vessicle. The welt resolved quickly. There were no labs/diagnostics performed. Additional information is not expected.
Age: 1.0
Sex: F
Vaccine: VARCEL
Symptoms: Chest X-ray, Herpes zoster
Clinical narrative: Information has been received from a registered nurse concerning 9 year old female patient with no previous medical history and allergies reported, who on 21-AUG-2000 was vaccinated with one dose of VARIVAX (Merck) (Lot number 657175/0498U, that was reported is valid for HIB conj vaccine. Concomitant therapy included Amoxicillin/Augmentin and Acyclovir-herpes simplex. On 23-FEB-2009, the patient was seen at the office, the patient was diagnosed with shingles at the back of the left back. On an unknown date, a chest X-ray was performed (results not provided). The patient's shingles at the back persisted. Additional information has been requested.
Age: 1.0
Sex: F
Vaccine: VARCEL
Symptoms: Rash erythematous, Rash papular
Clinical narrative: Information has been received from a health professional concerning a 10 year old female patient with no allergies at time of vaccination and allergic reaction to Augmentin which caused hives, who on 07-SEP-1999 was vaccinated with the first dose of VARIVAX (Merck) SC. Subsequently, the patient experienced pink papular rash in head, legs and arms. On an unspecified date, the patient recovered. Additional information has been requested.
Age: 4.0
Sex: M
Vaccine: VARCEL
Symptoms: Chills, Fatigue, Pruritus, Pyrexia, Rash erythematous
Clinical narrative: Information has been received from a physician concerning a patient who on 05-Mar-1997 was vaccinated with the first dose of VARIVAX (Oka/Merck) (lot # 621192/1550D) Subcutaneously. It was reported that on 05-Jan-2004 the patient experienced fever 100.7 for 2 days, fatigue, chills, multiple lesions with red base, some vesicles and some papular, itchy scalp and ankles "very Pruritic additional information has been requested. This is in follow-up to report(s) previously submitted on 5/15/2009. Follow up information has been received from a Licensed Practical Nurse (L.P.N.) who reported that a 16 year old male patient with no pre-existing allergies or medical conditions was vaccinated on 05-MAR-1997 with the first dose of VARIVAX (Merck) (Lot # 621192/1550D) subcutaneously. There was no illness at time of vaccination. It was reported that on 5-JAN-2009 the patient experienced fever of 100.7 degrees F, multiple red lesions, fatigue, chills, itchy scalp and ankles and red hives papular. The patient had recovered on 11-JAN-2009. Additional information is not expected.
Age: 4.0
Sex: M
Vaccine: VARCEL
Symptoms: Rash papular, Urticaria
Clinical narrative: Information has been received from a physician concerning a patient who on 05-Mar-1997 was vaccinated with the first dose of VARIVAX (Oka/Merck) (lot # 621192/1550D) Subcutaneously. It was reported that on 05-Jan-2004 the patient experienced fever 100.7 for 2 days, fatigue, chills, multiple lesions with red base, some vesicles and some papular, itchy scalp and ankles "very Pruritic additional information has been requested. This is in follow-up to report(s) previously submitted on 5/15/2009. Follow up information has been received from a Licensed Practical Nurse (L.P.N.) who reported that a 16 year old male patient with no pre-existing allergies or medical conditions was vaccinated on 05-MAR-1997 with the first dose of VARIVAX (Merck) (Lot # 621192/1550D) subcutaneously. There was no illness at time of vaccination. It was reported that on 5-JAN-2009 the patient experienced fever of 100.7 degrees F, multiple red lesions, fatigue, chills, itchy scalp and ankles and red hives papular. The patient had recovered on 11-JAN-2009. Additional information is not expected.
Age: 12.0
Sex: F
Vaccine: VARCEL
Symptoms: Herpes zoster
Clinical narrative: Information has been received from a licensed practical nurse concerning a 12 year old female patient with no previous medical history and allergies reported, who on 13-NOV-1997 when she was 13 month old was vaccinated with a dose of VARIVAX vaccine (Oka/Merck). There was no concomitant medication. On 23-FEB-2009, the patient was diagnosed with shingles. The patient's shingles persisted. The patient sough medical attention at the office. Additional information has been requested.
Age: 1.0
Sex: M
Vaccine: VARCEL
Symptoms: Rash papular
Clinical narrative: Information has been received from a Licensed Practical Nurse concerning a 4 year old male patient who on 08-JUN-2005 was vaccinated with first dose of VARIVAX (Oka/Merck) (Lot # 650224/1107).  Subcutaneously on 01-FEB-2009 the patient experienced 2-3 papules vesicular lesions in face and neck.  The patient did not seek medical attention.  Additional information is not expected.
Age: 7.0
Sex: M
Vaccine: VARCEL
Symptoms: Herpes zoster
Clinical narrative: Information has been received from a registered nurse (school nurse) concerning a 7 year old male who in approximately 2008, about 1 year ago, was vaccinated with VARIVAX. In February 2009, the patient was diagnosed with shingles. At the time of this report, the patient was recovered. The patient sought medical attention in physician's office. No further information is available.
Sex: U
Vaccine: VARCEL
Symptoms: Rash
Clinical narrative: Information has been received from a registered nurse concerning a child who on an unspecified date was vaccinated with the first dose of VARIVAX (Merck) (lot # was not available).  The nurse stated that the patient developed a rash and a possible outbreak of chickenpox within 48 hours after receiving VARIVAX.  The patient sought unspecified medical attention.  The patient's outcome is unknown.  Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Rash
Clinical narrative: Information has been received from a registered nurse concerning a child who on an unspecified date was vaccinated with a second dose of VARIVAX (lot # was not available). The nurse stated that the patient developed a rash within 5-7 days after receiving VARIVAX. It is not known if the rash was a varicella rash. The patient sought unspecified medical attention. At the time of reporting, the patient's outcome was unknown. Additional information has been requested. This is one of several reports received from the same source.
Age: 4.0
Sex: M
Vaccine: VARCEL
Symptoms: Skin lesion, Varicella post vaccine
Clinical narrative: Information has been received from a consumer concerning her 4 year old son with no drug reactions or allergies who, "about 3 years ago", in approximately 2006 was vaccinated with a first dose of VARIVAX (Merck).  "A few days ago", on 17-FEB-2009 the patient developed a breakthrough of chicken pox and had about 20 lesions.  Unspecified medical attention was sought but no laboratory test was performed.  The patient was scheduled to receive his second dose of VARIVAX in the next two weeks.  At the time of this report, 18-FEB-2009, the event persisted.  The patient's twin brother also experienced an AE following (WAES# 0902USA03715).  Additional information has been requested.
Age: 29.0
Sex: F
Vaccine: VARCEL
Symptoms: Varicella zoster serology negative
Clinical narrative: Information has been received from a physician concerning a 29 year old female with no medical history who in her teens, was vaccinated with two doses of VARIVAX (Merck) (lot # not reported).  Subsequently the patient had a negative varicella titer.  At the time of the report, on 24-FEB-2009, the patient has not recovered.  The patient was seen in the office.  Additional information has been requested.
Age: 46.0
Sex: M
Vaccine: VARCEL
Symptoms: Pain, Paraesthesia, Rash vesicular, Secondary transmission
Clinical narrative: Information has been received from a pharm D. concerning a 46 year old male with HIV, penicillin allergy and drug hypersensitivity to sulfa and a history of herpes zoster prior to this episode who was vaccinated with VARIVAX (OKA/Merck). Concomitant therapy included SUSTIVA, lamivudine, COMBIVIR, and ZANAFLEX. The patient experienced zoster after exposure to a child who recently was administered VARIVAX (Oka/Merck) on 20-FEB-2009. The patient visited the child on 22-FEB-2009. On 23-FEB-2009 the patient experienced zoster-like lesions on his hands, pain and tingling in that area. The patient sough medical attention via phone. At this time of reporting, the patient's zoster-like lesions on his hands and pain in that area and tingling in that area persisted. Additional information has been requested.
Age: 63.0
Sex: M
Vaccine: VARCEL
Symptoms: Wrong drug administered
Clinical narrative: Information has been received from a doctor of pharmacy concerning an over 60 year old male physician with a history of chickenpox who on 25-FEB-2009 was vaccinated with VARIVAX (Oka/Merck) instead of ZOSTAVAX (Oka/Merck) (MSD) because of a name confusion.  The physician was not experiencing any known symptoms.  The patient did not perform any lab diagnostics studies.  The patient sought medical attention - visit to the pharmacy.  Follow-up information has been received from a doctor of pharmacy concerning a 63 year old male physician/patient who wanted to order a vaccine for himself.  The patient knew at the time he ordered the vaccine that he needed one shot.  He requested VARIVAX (Oka/Merck) thinking that only one shot was needed.  He administered himself the VARIVAX (Oka/Merck) and later realized that VARIVAX (Oka/Merck) required more than one shot in a series.  He then realized that what he actually needed was shot of ZOSTAVAX (Oka/Merck).  The patient did not experience any adverse event.  No further information is available.
Age: 1.0
Sex: M
Vaccine: VARCEL
Symptoms: Varicella post vaccine
Clinical narrative: Information has been received fro a nurse practitioner concerning a 6 year old male who on 15-SEP-2003 was vaccinated with a dose of VARIVAX (Oka/Merck). The patient also received a dose of MMR II (Oka/Merck upgrade process) on 10-SEP-2007. On 31-JAN-2007. On 31-JAN-2009 the patient developed a pretty severe case of chickenpox. The patient sought unspecified medical attention. Additional information has been requested.
Age: 38.0
Sex: F
Vaccine: VARCEL
Symptoms: Lymphadenopathy, Rash vesicular
Clinical narrative: Information has been received from a medical assistant concerning 38 year old female with no pertinent medical history and no known allergies, who on 12-FEB-2009 was vaccinated with 0.5 ml of a dose of VARIVAX (Oka/Merck) (Lot not reported) subcutaneously. There was no concomitant medication. On 21-FEB-2009 the patient developed swollen lymph nodes in her neck and a Varicella like rash. The patient had the rash on her chest, face and back. On an unspecified date the patient recovered. Additional information has been requested.
Age: 1.0
Sex: M
Vaccine: PNC, VARCEL
Symptoms: Scab, Varicella post vaccine
Clinical narrative: Information has been received from a physician concerning a 13 month old male with no medical history or drug allergy who on 31-DEC-2008 was vaccinated with single dose of series of VARIVAX (Oka/Merck) (660669/1381X) and PREVNAR (lot # C71975). On 20-JAN-2009 the patient came into the office with a Varicella rash from head to toe. The physician reported that the patient had recovered and was unsure if they would give the booster of VARIVAX (Oka/Merck). The patient did not perform any lab diagnostics study. Follow-up information has been received from a health professional concerning the patient who on 31-DEC-2008 at 11:30 AM was vaccinated with the first dose of VARIVAX (Oka/Merck) (660669/1318X, SC) and the fourth dose of PREVNAR (lot # C71975, IM in the left thigh). The patient was seen with vesiculopapular rashes. Rashes developed on 16-JAN-2009 (previously reported on 20-JAN-2009) on neck, torso and spread to the extremities. Some of the rashes were drying out and scabbing over, while others were still developing. It was reported the patient did not have any illness at time of vaccination and no pre-existing allergies, birth defects, or medical conditions. At time of the report the patient was recovered (also reported as unknown).
Age: 2.0
Sex: M
Vaccine: VARCEL
Symptoms: Dysphemia, Eye pain, Head banging, Toothache
Clinical narrative: Information has been received from a consumer concerning her 25 month old son with allergy to eggs and oatmeal, patient's mother with Sjoren's syndrome and the patient had a history of a hot, red face, limping gait, decreased urination, loose stools, increased drooling and "unusual behavior" such as staring and rocking as well as hitting his arms and legs seven days after vaccinated with the first dose of measles virus vaccine live (Enders-Edmonston) (MSD) (WAES # 0902USA04542) who on 21-JAN-2009 was vaccinated with the first dose of VARIVAX (Merck).  On 28-JAN-2009, "seven days after receiving his first dose", the patient exhibited stuttering, tooth and eye pain, as well as banging his head on the floor.  The patient was examined by his physician and the physician had ordered unspecified tests to rule out auto-immune disease, especially Sjogrens syndrome.  The test results were pending at the time of the report.  The consumer reported that her son's symptoms resolved slowly over the course of the last month and completely resolved as of 25-FEB-2009.  No further information is available.
Age: 36.0
Sex: F
Vaccine: VARCEL
Symptoms: Accidental exposure, Eye irritation
Clinical narrative: Information has been received from a office secretary concerning 36 year old mother female who on 27-FEB-2009 was splashed in the eye with VARIVAX (Oka/Merck). The mother's eye was burning. The mother was in with a patient coming in to see the office physician but had not been examined yet. The mother's eye burning persisted. An ophthalmologist was contacted. Additional information has been requested.
Sex: U
Vaccine: VARCEL, VARZOS
Symptoms: No adverse event, Wrong drug administered
Clinical narrative: Information has been received from a registered nurse concerning a patient with egg allergy and a history of chickenpox who on an unspecified date was vaccinated with VARIVAX (Oka/Merck) instead of ZOSTAVAX (Oka/Merck) by mistake. The nurse reported this was a product confusion "because the products sound the same". No adverse reactions reported. Additional information has been requested.
Age: 2.0
Sex: F
Vaccine: VARCEL
Symptoms: Exfoliative rash
Clinical narrative: Information has been received from a nurse practitioner concerning a 47 month old (age estimated) female who in July 2007, was vaccinated with one dose of VARIVAX (Oka/Merck) 0.5 ml, SQ. There was no concomitant medication. The last couple of days, in February 2009, the patient had a possible breakthrough chicken pox. The patient's parent stated that there were scaly spots on several areas of her body. The patient did not recovered and sought medical attention as her parent spoke with the nurse. The patient had not been seen yet. This is one of several reports received from the same source. Additional information has been requested.
Age: 17.0
Sex: F
Vaccine: VARCEL
Symptoms: Injection site vesicles
Clinical narrative: Information has been received from a physician concerning a 17 year old female who on 13-FEB-2009 was vaccinated with a 0.5mL dose of VARIVAX (Oka/Merck) (route and lot number not provided). The physician reported that in approximately February 2009, after receiving VARIVAX (Oka/Merck) the patient experienced a "shingles like reaction at the injection site". Subsequently, the patient recovered from the event on an unspecified date. Additional information has been requested.
Age: 37.0
Sex: F
Vaccine: VARCEL
Symptoms: Varicella post vaccine
Clinical narrative: Information has been received from a physician concerning a female between 30 and 40 years old who on an unknown date was vaccinated with a 0.5mL dose of VARIVAX (Oka/Merck) (route and lot number not provided). Within one week of receiving VARIVAX (Oka/Merck) the patient experienced "a pretty bad case of chicken pox all over (face, arms, back, legs)". The patient was recovering from the event at the time of report. It was not specified if the patient sought medical attention. Follow-up information was received from the physician indication that she was 27 year old white female patient (previously reported as 30 to 40 year old), who in the PM of 22-FEB-2009, was vaccinated with the first dose of VARIVAX (Oka/Merck) (Lot # 660339/0487X), intramuscularly. On 20-Feb-2009, the patient developed full blown Varicella on her face, trunk, arms and back. On 28-FEB-2009, the patient sought unspecified medical attention. Additional information is not expected.
Age: 6.0
Sex: F
Vaccine: VARCEL
Symptoms: Headache, Varicella post vaccine, Vomiting
Clinical narrative: Information has been received from a nurse practitioner concerning her 6 year old grand daughter who in Summer 2008 (approximately June 2008), was vaccinated with second dose of VARIVAX (Oka/Merck) (dose, route and lot number not provided). The reporter stated that the patient received the second dose of VARIVAX (Oka/Merck) during Summer 2008. On 28-FEB-2009 the patient broke out with chickenpox. The patient also had headache and was vomiting. At the time of the report the patient had not recovered from the events, the patient sought unspecified medical attention. Additional information has been requested.
Age: 45.0
Sex: F
Vaccine: VARCEL
Symptoms: Antibody test, Disturbance in attention, Malaise, Pruritus, Rash
Clinical narrative: Information has been received from a registered nurse concerning a female in her late 30's who four to five weeks ago was vaccinated with the first dose of VARIVAX (Merck). The week after vaccination, the patient felt "out of sorts". Symptoms included difficulty concentrating at work. At an unspecified time period, she developed abdominal itching and by the third week following vaccination she had a rash covering her entire abdomen. The nurse stated that the patient described the rash as looking like "mosquito bites". The patient recovered without treatment. The patient did not seek medical attention and mentioned her symptoms to the nurse when she came to her appointment for second dose of VARIVAX (Merck). At that point the rash had resolved. The nurse decided not to administer second dose of VARIVAX (Merck). There was an antibody titer test with no results available. Additional information has been requested. 06/18/10 Follow-up information has been received from the registered nurse concerning the 45 year old female Director with rheumatoid arthritis and no known allergies who on 02-FEB-2009 at approximately 15:00 received the first dose of VARIVAX (lot # 661642/1135X), SQ in her left upper arm. On 3-MAR-2009 the patient was feeling "out of sorts-out of control". The patient stated that she kenw somethin was wrong but she didn't know how to fix it. The second week the patient felt better and stated that "the light switch turned back on". However she then developed an intense itching (no urticaria). This lasted approximately one week. The third week, she developed a mosquito-like patchy rash (no itching) which was sore. She could not put any pressure on it or touch it. She also developed small red "bumps" after the mosquito bite-like rash, which were not fluid filled or sore. On approximately 15-MAR-2009 she recovered. No further information is available.
Sex: U
Vaccine: VARCEL
Symptoms: Antibody test negative, Varicella zoster serology negative
Clinical narrative: Information has been received from a registered nurse concerning a patient who a couple years ago was vaccinated with the first and second doses of VARIVAX (Merck). It was reported that the patient who had received two doses of VARIVAX (Merck) tested negative for varicella antibody titers on an unspecified date. Additional information is not expected.
Sex: U
Vaccine: VARCEL
Symptoms: Abdominal pain upper
Clinical narrative: Information has been received from a physician concerning a patient who on unspecified dates was vaccinated with first and second dose of VARIVAX (Merck) (dose, route and lot number not provided). The physician reported that the patient developed a stomachache 3 minutes after receiving the second dose of VARIVAX (Merck). The patient recovered from the event on an unspecified date. The patient sought medical attention at the office. Additional information has been requested.
Age: 5.0
Sex: M
Vaccine: VARCEL
Symptoms: Syncope
Clinical narrative: Information has been received from a physician concerning a 5 year old male who was vaccinated with a second dose of VARIVAX (Merck). The patient fainted after receiving the VARIVAX (Merck). The patient sought medical attention through an office visit. At the time of this report the patient had recovered. Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Varicella post vaccine
Clinical narrative: Information has been received from a nurse practitioner concerning a number of patient who were vaccinated with VARIVAX (Oka/Merck). The patients were getting varicella breakthrough chicken pox in her area. No further information provided. This is one of several reports from the same source. Additional information has been requested.
Age: 1.3
Sex: F
Vaccine: MMR, VARCEL
Symptoms: Herpes zoster, Rash papular
Clinical narrative: Information has been received from a registered nurse concerning a 27 month old female with no pre-existing allergies, birth defects, medical conditions or illness at time of vaccination who on 21-FEB-2008 was vaccinated with the first dose of VARIVAX (Merck) SC (lot # 659737/1783U). Other vaccine received on 21-FEB-2008 included MMR II SC (lot # 657117/1312U). On 25-FEB-2009 the patient developed on upper left arm a cluster of papules scattered down arm - shingles. She saw the doctor with instructions to cover the arm and take BENADRYL and TYLENOL. Subsequently, the patient recovered from shingles. No further information is available.
Age: 8.0
Sex: F
Vaccine: FLUX, VARCEL
Symptoms: Injection site pain, Injection site reaction, Injection site vesicles
Clinical narrative: Information has been received from a registered nurse concerning an 8 year old female who on an unspecified date was vaccinated with a second of VARIVAX (Oka/Merck) (lot# 66164/0974X). Concomitant therapy included a dose of influenza virus vaccine (unspecified). Twelve days after the vaccination the patient developed a varicella reaction at the injection site. The varicella reaction was described as localized at the injection site, painful and pox like. Subsequently, the patient recovered from the varicella reaction. This is one of several reports from the same source. Additional information has been requested.
Age: 17.0
Sex: F
Vaccine: HEPA, VARCEL
Symptoms: Injection site mass
Clinical narrative: Information has been received from a physician concerning an approximately 17 year old female with penicillin allergy and clindamycin allergy who on 22-OCT-1998 was vaccinated with a first dose of VARIVAX (Merck). On an unspecified date the patient was vaccinated with a second dose of VARIVAX (Merck). Concomitant therapy included Hep A (unspecified) in the other arm. On the day after the vaccination, the patient developed a big lump at the injection site. The lump was 2"X3" and lasted 5 days. It was treated with BENADRYL and ice. The physician "knows" that the big lump was the result of VARIVAX (Merck) because "she has had other patients with the same reaction." The patient sought medical attention by mentioning it to a doctor. Subsequently, the patient recovered. This is one of two reports from the same source. Additional information has been requested.